Beyond the prescription: Global observations on the social implications of GLP-1 receptor agonists for weight loss
This means faster recovery, better energy, and a stronger immune system
Glucagon-like peptide-1 (GLP-1) receptor agonists represent a class of medications primarily used for managing type 2 diabetes and, in some formulations, for chronic weight management
The result is prolonged nausea, vomiting, reflux, and abdominal heaviness that can last hours after a single meal
These medications work by mimicking the action of the naturally occurring GLP-1 hormone, which stimulates insulin secretion, suppresses glucagon release, slows gastric emptying, and reduces appetite
*Compounded medications are not approved by the FDA and are not tested by the FDA for safety and efficacy